1. In-utero exposure to immunosuppressive medications resulting in abnormal newborn screening for severe combined immunodeficiency: a case series on natural history and management

   • Hallie A. Carol
   • Elisa N. Ochfeld
   • Aisha Ahmed

   Letter to the Editor 03 June 2022 Pages: 561 - 565

   

2. Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis

   • Han-qi Zhang
   • Si-Wei Yang
   • Ming-Yi Zhao

   Review 11 July 2022 Pages: 566 - 577

   

3. Insights into inflammasome regulation: cellular, molecular, and pathogenic control of inflammasome activation

   • Naveen Challagundla
   • Bhaskar Saha
   • Reena Agrawal-Rajput

   Review 24 May 2022 Pages: 578 - 606

   

4. Potential therapeutic strategies for myocardial infarction: the role of Toll-like receptors

   • Sumra Komal
   • Nimrah Komal
   • Sheng-Na Han

   Review 24 May 2022 Pages: 607 - 623

   

5. Livin promotes Th2-type immune response in airway allergic diseases

   • Yue Wang
   • Zhiyu Xiang
   • Pingchang Yang

   Original Article Open access 18 June 2022 Pages: 624 - 632

   

6. High mobility group box 1 (HMGB1) inhibition attenuates lipopolysaccharide-induced cognitive dysfunction and sickness-like behavior in mice

   • Devlina Ghosh
   • Aditi Singh
   • Neeraj Sinha

   Original Article 07 June 2022 Pages: 633 - 643

   

7. Th17 and Th1 cells in systemic lupus erythematosus with focus on lupus nephritis

   • Raouia Fakhfakh
   • Zeineb Zian
   • Hatem Masmoudi

   Original Article 06 June 2022 Pages: 644 - 653

   

8. Effect of different cytokines in combination with IL-15 on the expression of activating receptors in NK cells of patients with Behçet’s disease

   • Nilgun Sallakci
   • Ilhan Tahrali
   • Gunnur Deniz

   Original Article 03 June 2022 Pages: 654 - 666

   

9. The ability of inflammatory markers to recognize infection in cancer patients with fever at admission

   • Lubei Rao
   • Kaijiong Zhang
   • Dongsheng Wang

   Original Article 28 June 2022 Pages: 667 - 677

   

10. Hydroquinone predisposes for retinal pigment epithelial (RPE) cell degeneration in inflammatory conditions

    • Niina Bhattarai
    • Maria Hytti
    • Anu Kauppinen

    Original Article Open access 04 June 2022 Pages: 678 - 687

    

11. Tryptanthrin attenuates TLR3-mediated STAT1 activation in THP-1 cells

    • Noriyuki Numao
    • Shogo Kawaguchi
    • Tadaatsu Imaizumi

    Original Article 06 June 2022 Pages: 688 - 697

    

12. Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome

    • Marcus Derigs
    • Hendrik Heers
    • Jörg Hänze

    Original Article Open access 23 June 2022 Pages: 698 - 707

    

13. The alterations of cerebrospinal fluid TNF-alpha and TGF-beta2 levels in early relapsing–remitting multiple sclerosis

    • Tomasz Grzegorski
    • Piotr Iwanowski
    • Jacek Losy

    Original Article 21 June 2022 Pages: 708 - 713

    

14. Low levels of the key B cell activation marker, HLA-DR, in COVID-19 hospitalized cases are associated with disease severity, dexamethasone treatment, and circulating IL-6 levels

    • Anthony Dobi
    • Arthur Dubernet
    • Philippe Gasque

    Brief Report 09 June 2022 Pages: 714 - 719